Biogen (BIIB) Q3 2025 Earnings Call Transcript Released
Biogen (BIIB) released its Q3 2025 earnings call transcript, featuring comments from CEO Christopher Turner and CFO Ranjith Roy. The transcript includes forward-looking statements and details about the company's financial reporting, including the exclusion of foreign currency impacts on sales and operating profit growth. The company also announced the date for its fourth-quarter earnings release.
Tickers: $BIIB
Topics: Biogen Earnings Call Financial Results Q3 2025